PNC-27 30 mg Research Peptide | Pure Lab Peptides Supply
Description
PNC-27 30 mg
Buy PNC-27 30 mg from Pure Lab Peptides Supply for laboratory research and analytical evaluation. This listing describes lyophilized peptide powder supplied in one boxed 3 mL vial.
PNC-27 is a designed peptide studied in cell-membrane research and investigations of HDM-2, a protein also known as MDM2. Researchers have explored how this peptide interacts with membrane-associated HDM-2 in specific experimental cell models. However, findings from published studies do not establish the identity, purity, or performance of a particular commercial batch.
Choose the Complete Construct
The original 2010 PNC-27 study describes a 32-residue construct that combines a p53-derived region with a membrane-active segment. Therefore, researchers should not interpret the number in the product name as the complete amino-acid count.
PNC-28 contains a different p53-derived region, so researchers should not treat it as interchangeable with PNC-27. Before comparing molecular specifications, check the full sequence, terminal chemistry, and supplied form against the reference material required by your method.
Additionally, a published reference sequence does not independently verify a purchased batch. Researchers should use appropriate analytical evidence to establish the identity of the material under evaluation.
The 30 mg label describes the listed amount of material, while the 3 mL measurement describes the vial’s capacity. Neither value specifies a prepared solution concentration or an experimental exposure level.
HDM-2 and Cell-Membrane Research
The original PNC-27 study used membrane-fraction analysis and fluorescence microscopy to examine HDM-2 and PNC-27 in cancer and nonmalignant cell models. The investigators reported that PNC-27 and HDM-2 appeared together at cancer-cell membranes, supporting further investigation of a membrane-associated mechanism.
Furthermore, the researchers engineered initially nonsusceptible MCF-10-2A cells to express full-length HDM-2 at the membrane. Those modified cells then showed susceptibility under the study conditions. This result highlights the importance of cellular context when interpreting the findings.
However, these observations do not establish that every nonmalignant cell will remain unaffected. The experiments involved specific cell systems and controls, and other models may produce different results. Likewise, these findings do not demonstrate a treatment outcome or guarantee equivalent selectivity for another cell type or commercial preparation.
Research Applications and Scientific Context
PNC-27 research may help investigators explore several analytical questions, depending on the documented construct and experimental design:
- Peptide characterization: Examine the identity and structural attributes of the specified peptide.
- Membrane-associated research: Investigate peptide behavior in controlled cell-membrane models.
- HDM-2 studies: Explore the relationship between HDM-2 localization and the responses observed in defined experimental systems.
- Comparative peptide analysis: Assess differences between PNC-27, PNC-28, and other constructs only when their sequences and structures are clearly established.
- Analytical method development: Evaluate suitable methods for peptide identity and purity assessment.
These areas describe research interests rather than established therapeutic benefits. Consequently, researchers should interpret results within the limits of the tested construct, cell model, controls, and measured endpoints.
Product Specifications
- Product name: PNC-27 30 mg
- Labeled quantity: 30 mg
- Material type: Designed research peptide, according to the supplied listing
- Format: Lyophilized powder
- Appearance: Confirm against the current product documentation
- Packaging: One boxed 3 mL vial
- Peptide sequence: Confirm the complete sequence in the applicable technical documentation
- Construct details: Verify the p53-derived region, membrane-active segment, and terminal chemistry
- Molecular formula: Confirm using the documented construct
- Molecular weight: Confirm using the documented construct and chemical form
- Purity: Review the applicable batch-specific analytical results
- Research applications: Peptide characterization, cell-membrane research, HDM-2 studies, and analytical method development
- Storage and stability: Follow instructions that apply to the supplied material
- Safety information: Consult the available product documents and relevant safety information
- Intended use: Laboratory research only
Specification note: The supplied listing does not include a complete product sequence, molecular formula, molecular weight, or numerical purity result. Therefore, this page does not assume those values or transfer specifications from a different peptide construct.
Review Product Documents and Batch Identity
Before using PNC-27 30 mg in a laboratory workflow, review the available product documents and compare the vial label with the applicable batch record. Then, assess identity, chromatographic purity, and measured content separately because each measurement answers a different question.
A purity percentage alone does not confirm the complete peptide sequence or establish every aspect of product quality. Similarly, a reference sequence from a published paper does not replace analytical verification of the supplied batch.
For further information, visit the COA and product documentation page. You can also visit Pure Lab Peptides Supply to explore the available product information.
Storage, Handling, and Research Use
Check the applicable technical documents for storage conditions, stability, and solvent compatibility. In addition, confirm the conditions for prepared material if your laboratory method requires a solution.
Do not assume that general supplier handling statements or results from another peptide construct establish the correct conditions for this vial. Instead, use material-specific information and follow your laboratory’s safety procedures.
Frequently Asked Questions
What is PNC-27 30 mg?
PNC-27 30 mg is listed as a designed research peptide supplied as lyophilized powder in one boxed 3 mL vial. Researchers should confirm the complete construct and batch details through the applicable product documentation.
Does PNC-27 contain 27 amino acids?
The number in the product name does not indicate the complete amino-acid count. The cited original study describes a 32-residue construct. However, researchers should verify the sequence of the specific material they intend to evaluate.
How does PNC-27 differ from PNC-28?
PNC-27 and PNC-28 use different p53-derived regions. Therefore, researchers should confirm the sequence and other structural details before comparing results or treating the constructs as reference materials.
What does the 30 mg label mean?
The 30 mg label indicates the stated quantity of material. It does not specify solution concentration or an experimental exposure level. Likewise, the 3 mL vial capacity describes the container rather than a preparation volume.
Does published research establish the performance of this product?
No. Published studies provide scientific context for the specific materials and experimental conditions they describe. Researchers must evaluate the identity and analytical documentation of the supplied batch separately.
Where can I review product documentation?
Visit the COA and product documentation page to review available records. Confirm that the documents correspond to the product and batch under evaluation.
Explore PNC-27 30 mg Research Material
Explore PNC-27 30 mg from Pure Lab Peptides Supply for laboratory research and analytical evaluation. Before ordering, review the available product documents and confirm the construct identity, labeled quantity, and relevant technical specifications.
Visit Pure Lab Peptides Supply or consult the COA and product documentation page for additional information.
For laboratory research only. Not for human or veterinary use.

















